Skip to search formSkip to main contentSkip to account menu

CD22 Expressing Cell Count

Known as: B-Cell Receptor CD22 Expressing Cell Count, CD22 
The determination of the amount of CD22 expressing cells per unit present in a sample.
National Institutes of Health

Related topics

Related topics

6 relations
CD22 antigenCD22 geneCD22 protein, humanCDISC SDTM Laboratory Test Terminology by Code

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
[Study on Immunophenotypes and Gene of Acute Lymphoblastic Leukemia].
OBJECTIVE To retrospectively analyze the immunophenotyping, fusion gene and gene mutation of 30 acute lymphoblastic leukemia (ALL… 
2016
2016
Иммунологические изменения у больных внебольничной пневмонией с сопутствующей ИБС под влиянием симвастатина
Introduction. Immunological changes in the elderly people with concomitant diseases affect all major parts of the immune status… 
2016
2016
GRANULAR ALL IN ADULT MALE: MASQUERADING AS AML
The presence of cytoplasmic granules in the blasts cells is a one of the main accepted and widely used morphological criteria to… 
2013
2013
Anti-CD20 and CD22 therapy is effective in non-Hodgkin lymphoma.
Inotuzumab ozogamicin may be more effective than rituximab alone in non-Hodgkin lymphoma. 
2013
2013
Immunological Changes In Patients Operated On Peritonitis
Restoration of cellular and humoral immunity observed in patients with local peritonitis, which shows the activeness and… 
2010
2010
[Establishment of a nude mouse model of highly metastatic gastric lymphoma constructed with orthotopic transplantation of surgical specimen].
OBJECTIVE To construct a mouse model of highly metastatic gastric lymphoma with orthotopic transplantation of human primary… 
2009
2009
CMC-544 (inotuzumab ozogamicin), an anti-CD22 immuno-conjugate of calicheamicin, alters the levels of target molecules of malignant B-cells
2009
2009
[Effect of enterosorption on immunologic parameters of patients with colorectal cancer in the postoperative period].
Our investigation was carried out on an assumption that end results among patients radically-treated for colorectal cancer might… 
2005
2005
[3-year results of clinical and immunological monitoring of patients with multiple sclerosis treated by copaxone].
Tipe 1 T-helper cells are of importance in development of multiple sclerosis (MS). Copaxone (TEVA, Israel) is one of the… 
2000
2000
CD79b expression in B-cell chronic lymphocytic leukemia.
Sir, CD79b monoclonal antibody (B29) identifies a Bcell restricted molecule that is part of the mb1/B29 disulphide-linked… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)